Audrey Dionne, MD
Associate Cardiologist, Department of Cardiology
Assistant Professor of Pediatrics, Harvard Medical School
Image
Audrey Dionne, MD
Associate Cardiologist, Department of Cardiology
Assistant Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
French
Education
Medical School
University of Sherbrooke
2013
Sherbrooke, Quebec
Canada
Internship
CHU Sainte-Justine
2014
Montreal , Quebec
Canada
Residency
CHU Sainte-Justine
2016
Montreal, Quebec
Canada
Fellowship
Boston Children's Hospital
2019
Boston
MA
Fellowship
Boston Children's Hospital
2020
Boston
MA
Certifications
American Board of Pediatrics (General)
Publications
Systemic Arterial Aneurysms in Kawasaki Disease: An Important Evidence Gap. View Abstract
Myocardial Infarction in Kawasaki Disease. View Abstract
Spectrum of Coronary Artery Involvement With Multisystem Inflammatory Syndrome in Children Versus Kawasaki Disease. View Abstract
CMR Findings in the Long-Term Outcomes After Multisystem Inflammatory Syndrome in Children (MUSIC) Study. View Abstract
Six-Month Outcomes in the Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children Study. View Abstract
ICU Admission Prediction for Patients With Kawasaki Disease or MIS-C Using Machine Learning. View Abstract
Safety of Ablation Within the Coronary Venous Sinus in Pediatric Patients. View Abstract
A Quality Improvement Initiative to Optimize Follow-Up in the New England Area for Pediatric Patients With Cardiovascular Implantable Electronic Devices. View Abstract
Thromboembolic Complications From Atrial Fibrillation and Atrial Flutter in Pediatrics and Young Adults: A Multicenter Study. View Abstract
Factors Associated With Shock at Presentation in Kawasaki Disease Versus Multisystem Inflammatory Syndrome in Children Associated With Covid-19. View Abstract
Design and rationale of the COVID vaccine-associated myocarditis/pericarditis (CAMP) study. View Abstract
Intraoperative Conduction Mapping to Reduce Postoperative Atrioventricular Block in Complex Congenital Heart Disease. View Abstract
Variation in the management and treatment of children with giant coronary artery aneurysm following Kawasaki disease. View Abstract
Calcium channel blockers and beta blockers in pediatric supraventricular tachycardia. View Abstract
Development and validation of an open-source pipeline for automatic population of case report forms from electronic health records: a pediatric multi-center prospective study. View Abstract
Efficacy and safety of early postoperative ablation in patients with congenital heart disease. View Abstract
Coronary Events Following Dobutamine Stress Cardiac Magnetic Resonance Imaging in Pediatric Patients. View Abstract
Identifying high-risk Fontan phenotypes using K-means clustering of cardiac magnetic resonance-based dyssynchrony metrics. View Abstract
Epicardial pacing outcomes in infants with heart block: Lead and device complications from a multicenter experience. View Abstract
Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design. View Abstract
Comparative utility of omnipolar and bipolar electroanatomic mapping methods to detect and localize dual nodal substrate in patients with atrioventricular nodal reentrant tachycardia. View Abstract
Epidemiology of Postoperative Junctional Ectopic Tachycardia in Infants Undergoing Cardiac Surgery. View Abstract
Premature ventricular contractions in children and young adults: natural history and clinical implications. View Abstract
Pediatric ECG-Based Deep Learning to Predict Left Ventricular Dysfunction and Remodeling. View Abstract
Updated Case Definition of MIS-C and Implications for Clinical Care. View Abstract
Cardiac Biomarkers Aid in Differentiation of Kawasaki Disease from Multisystem Inflammatory Syndrome in Children Associated with COVID-19. View Abstract
Ventricular dyssynchrony late after the Fontan operation is associated with decreased survival. View Abstract
Elevation of IL-17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders. View Abstract
Hypertrophic Cardiomyopathy and Ventricular Preexcitation in the Young: Cause and Accessory Pathway Characteristics. View Abstract
Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease. View Abstract
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium. View Abstract
Retroflexed catheter course reduces the risk of right free wall accessory pathway recurrence. View Abstract
Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry. View Abstract
Clinical implications of a unique delta wave pattern in patients with left-sided Wolff-Parkinson-White. View Abstract
Insight into the Role of the Child Opportunity Index on Surgical Outcomes in Congenital Heart Disease. View Abstract
MIS-C across three SARS-CoV-2 variants: Changes in COVID-19 testing and clinical characteristics in a cohort of U.S. children. View Abstract
Clinical risk prediction score for postoperative accelerated junctional rhythm and junctional ectopic tachycardia in children with congenital heart disease. View Abstract
Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in Children. View Abstract
Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis. View Abstract
Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children. View Abstract
Tachyarrhythmias During Hospitalization for COVID-19 or Multisystem Inflammatory Syndrome in Children and Adolescents. View Abstract
A machine-learning algorithm for diagnosis of multisystem inflammatory syndrome in children and Kawasaki disease in the USA: a retrospective model development and validation study. View Abstract
Radiofrequency Catheter Ablation for Pediatric Atrioventricular Nodal Reentrant Tachycardia: Impact of Age on Procedural Methods and Durable Success. View Abstract
Multiple QRS Morphologies: Findings on an Initial Newborn ECG. View Abstract
Follow-up cardiac magnetic resonance in children with vaccine-associated myocarditis. View Abstract
Multicenter Validation of a Machine Learning Algorithm for Diagnosing Pediatric Patients with Multisystem Inflammatory Syndrome and Kawasaki Disease. View Abstract
An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. View Abstract
Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination. View Abstract
Deep Learning-Based Approach to Automatically Assess Coronary Distensibility Following Kawasaki Disease. View Abstract
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children. View Abstract
Author's Response. View Abstract
Coagulation profiles and viscoelastic testing in multisystem inflammatory syndrome in children. View Abstract
Comparison of coronary artery measurements between echocardiograms and cardiac CT in Kawasaki disease patients with aneurysms. View Abstract
The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives. View Abstract
Coronary artery aneurysms in children is not always Kawasaki disease: a case report on Takayasu arteritis. View Abstract
Differentiating multisystem inflammatory syndrome in children: a single-centre retrospective cohort study. View Abstract
Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome. View Abstract
Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children, Using Strain Analysis. View Abstract
Rapid ascending aorta stiffening in bicuspid aortic valve on serial cardiovascular magnetic resonance evaluation: comparison with connective tissue disorders. View Abstract
Socioeconomic and Racial and/or Ethnic Disparities in Multisystem Inflammatory Syndrome. View Abstract
The Electrocardiogram in Multisystem Inflammatory Syndrome in Children: Mind Your Ps and Qs. View Abstract
Cardiac hemodynamics in fetuses with transposition of the great arteries and intact ventricular septum from diagnosis to end of pregnancy: longitudinal follow-up. View Abstract
Variation in the management of Kawasaki disease in Australia and New Zealand: A survey of paediatricians. View Abstract
Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. View Abstract
Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. View Abstract
Risk Factors for Early Recurrence Following Ablation for Accessory Pathways: The Role of Consolidation Lesions. View Abstract
Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis. View Abstract
Management of Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Survey From the International Kawasaki Disease Registry. View Abstract
Atrioventricular Block in Children With Multisystem Inflammatory Syndrome. View Abstract
Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. View Abstract
Value of provocative electrophysiology testing in the management of pediatric patients after congenital heart surgery. View Abstract
Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP). View Abstract
Value of Troponin Testing for Detection of Heart Disease in Previously Healthy Children. View Abstract
Anti-thrombosis management of patients with Kawasaki disease: Results from an international survey. View Abstract
Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease. View Abstract
Variation in the management of Kawasaki disease. View Abstract
Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis. View Abstract
Profile of resistance to IVIG treatment in patients with Kawasaki disease and concomitant infection. View Abstract
A Decade of NT-proBNP in Acute Kawasaki Disease, from Physiological Response to Clinical Relevance. View Abstract
Difference Between Persistent Aneurysm, Regressed Aneurysm, and Coronary Dilation in Kawasaki Disease: An Optical Coherence Tomography Study. View Abstract
Myocarditis and Kawasaki disease. View Abstract
Dynamic QT Interval Changes from Supine to Standing in Healthy Children. View Abstract
Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease. View Abstract
N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease. View Abstract
Importance of anatomical dominance in the evaluation of coronary dilatation in Kawasaki disease. View Abstract
Fatal Kawasaki disease with incomplete criteria: Correlation between optical coherence tomography and pathology. View Abstract
Coronary Wall Structural Changes in Patients With Kawasaki Disease: New Insights From Optical Coherence Tomography (OCT). View Abstract
Interferon-gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in Graves' disease. View Abstract
Locations